]>
IRCT20200905048625N3 IRCT 2024-02-05 Tehran University of Medical Sciences A new washing protocol to sterilize the urinary system A new washing protocol to sterilize the urinary system during percutaneous nephrolithotomy surgery 2024-04-13 anticipated 50 Complete https://irct.ir/trial/66816 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: -, Randomization description: The present study is a single -blind, randomized clinical trial study. After random sequencing by the methodologist using the sealed envelope online site, the constructed sequence will be provided to a technician outside the research team. Blocks of four (A or B) are placed, Blinding description: The present study is a single-blind clinical trial study in which the patients are not informed about the type of intervention. The patient does not know whether he is in the intervention or control group due to being unconscious, and he cannot be informed about it in any way after the surgery. N/A kidney stones. Intervention 1: Intervention group: Urinary system sterilization during percutaneous nephrolithotomy surgery with 10cc of 7.5% betadine solution (PovidoneIodine solution 10% PEJHAN CHEMI 250ml), Once during washing. Intervention 2: Control group: Urinary system sterilization during percutaneous nephrolithotomy surgery with 10cc sterile water, (Sterile water, free of DNase and RNase, Acell Teb Rad MED), Once during washing. Yes - There is a plan to make this available What will be shared: Demographic information anonymously When: One year after publication To whom: Researchers working in academia, physicians, surgeons and hospitals Conditions: Any analysis can be done with the consent of the main researcher Where to obtain: Sina Hospital, Urology Research Center, Dr. Seyed Reza Hosseini 00982166348560 How to obtain: After reviewing the information by the administrator and epidemiologist, the patient information will be available for the applicant by the provision of a patient's privacy. Comments: -
public Dr Akram Mirzaei
Urology Research Center- Sina Hospital - Imam Khomeini St
Tehran Iran (Islamic Republic of) 1136746911 +98 21 6634 8560 mirzaee.scholar@gmail.com Tehran University of Medical Sciences scientific Dr Seyed Reza Hosseini
Urology Research Center- Sina Hospital - Imam Khomeini St
Tehran Iran (Islamic Republic of) 1136746911 +98 21 6634 8560 srhoseini@tums.ac.ir Tehran University of Medical Sciences Iran (Islamic Republic of) Patients with indications for percutaneous nephrolithotomy surgery Consent to participate in the study 17 years 70 years Both Immunocompromised patients Taking drugs that cause immunodeficiency Patients with a family history of thyroid problems N21 Calculus of lower urinary tract Treatment - Other Treatment - Other Intervention group: Urinary system sterilization during percutaneous nephrolithotomy surgery with 10cc of 7.5% betadine solution (PovidoneIodine solution 10% PEJHAN CHEMI 250ml), Once during washing. Control group: Urinary system sterilization during percutaneous nephrolithotomy surgery with 10cc sterile water, (Sterile water, free of DNase and RNase, Acell Teb Rad MED), Once during washing. Post-surgical infections. Timepoint: 24 and 48 hours after surgery. Method of measurement: Blood culture, urine culture, ESR, CRP, CBC, and body temperature measurement. Sodium measurement. Timepoint: 24 and 48 hours after the operation. Method of measurement: Biochemical test-Sodium assay kit. Potassium measurement. Timepoint: 24 and 48 hours after the operation. Method of measurement: Biochemical test-Potassium assay kit. Chloride measurement. Timepoint: 24 and 48 hours after the operation. Method of measurement: Biochemical test-Chlorine test kit. Tehran University of Medical Sciences Approved 2022-10-23 Research Ethics Committee, Sina Hospital Room 206, Ethics Committee Office، Second Floor, Administrative Building،Sina Hospital، Imam Khomeini Street,Tehran,Iran Tehran Tehran Iran (Islamic Republic of)